HEALTHBLOOMBERG
Akeso To Boost Manufacturing Of Cancer Drug
Akeso is increasing the production of a cancer drug. The company aims to enhance manufacturing capacity for the treatment.
Mentioned
Related Signal
Adjacent reporting
- Why JSW Steel is Boosting Capacity
- Tech’s Red-Hot Rally Is Leaving Nvidia Far Behind
- Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million
- Novo Raises Forecast as Wegovy Pill Fuels Sales
- Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision